期刊文献+

氨溴索联合多巴胺治疗新生儿感染性肺炎的疗效评价 被引量:10

Evaluation on the therapeutic effects of Ambroxol combined with Dopamine in the treatment of neonatal infectious pneumonia
原文传递
导出
摘要 目的:分析氨溴索联合多巴胺治疗新生儿感染性肺炎(NIP)的疗效,为合理制订临床治疗方案提供研究依据。方法:选取2017年1月~2019年1月的202例NIP患儿作为研究对象,应用随机数字表法将其分为研究组和对照组,每组各101例。对照组患儿在常规对症治疗基础上给予盐酸氨溴索静脉滴注,研究组患儿在对照组疗法基础上加用多巴胺静脉滴注,两组患者均连续治疗7d。对两组患儿的呼吸困难缓解时间、喘息消失时间、咳嗽消失时间、肺部啰音消失时间、住院时间进行记录和对比。对两组患儿治疗前、后的血清清白细胞介素(IL)-2、IL-6、IL-10、心肌酶谱指标水平及外周血血小板计数(PLT)、血小板压积(PCT)、血小板分布宽度(PDW)、平均血小板体积(MPV)等血小板参数指标进行检测和比较。结果:研究组患儿的呼吸困难缓解时间、喘息消失时间、咳嗽消失时间、肺部啰音消失时间、住院时间均短于对照组,差异均有统计学意义。经治疗后,两组患儿的血清IL-2及PLT水平均较治疗前上升,血清IL-6、IL-10、心肌酶谱指标水平及PCT、PDW、MPV水平均较治疗前下降,差异均有统计学意义,研究组患儿治疗前、后的上述指标的差值均高于对照组,差异均有统计学意义。结论:与应用氨溴索治疗相比较,联合应用氨溴索和多巴胺对NIP患儿进行治疗,能够快速缓解患儿的主要临床症状,降低炎症反应程度,改善心肌酶谱指标和血小板参数指标,有利于提高治疗效果,改善患儿的预后。 Objective To analyze the therapeutic effects of Ambroxol combined with Dopamine in the treatment of neonatal infectious pneumonia(NIP)to provide research basis for rational formulation of clinical treatments.Methods 202 children with NIP from January of 2017 to January of 2019 were selected as the study subjects.They were divided into the study group and the control group by random number table method,101 cases were included into each group.The children in the control group were treated with intravenous drip of Ambroxol Hydrochloride on the basis of routine symptomatic treatments,while the children in the study group were treated with intravenous drip of Dopamine Hydrochloride on the basis of the therapy of the control group.The children in both groups were treated continuously for 7 days.The time for dyspnea remission,the time for wheezing disappearance,the time for cough disappearance,the time for lung rale disappearance,the hospitalization time between the children in the two groups were recorded and compared.The levels of serum interleukin(IL)-2,IL-6,IL-10,myocardial enzymogram indicators and the platelet parameters such as platelet count(PLT),plateletcrit(PCT),platelet distribution width(PDW),mean platelet volume(MPV)in the peripheral blood before and after the treatments between the patients in the two groups were measured and compared.Results The time for dyspnea remission,the time for wheezing disappearance,the time for cough disappearance,the time for lung rale disappearance,the hospitalization time of the children in the study group were shorter than those in the control group,the differences were statistically significant.After the treatments,the serum IL-2 levels and the PLT levels of the children in the two groups were higher than those before the treatments,the serum IL-6,IL-10 levels,the serum myocardial enzymogram indicators levels and the PCT,PDW,MPV levels were lower than those before the treatments,the differences were statistically significant.The differences of the above indicators between before and after the treatment of the children in the study group were higher than those in the control group,the differences were statistically significant.Conclusion Compared with the application of Ambroxol,the combination application of Ambroxol and Dopamine can quickly relieve the main clinical symptoms,reduce the degree of inflammations,improve the myocardial enzymogram indicators and the platelet parameters in NIP children,which is benefit to improve the therapeutic effects and prognosis.
作者 杨宁 纪校敏 罗丽平 Yang Ning;Ji Xue-min;Luo Li-ping(Department of Neonatology,Dezhou People's Hospital,Dezhou 253000,China;Department of Pediatrics,Ningjin People's Hospital,Ningjin 253000,China)
出处 《湖南师范大学学报(医学版)》 2021年第3期233-237,共5页 Journal of Hunan Normal University(Medical Sciences)
关键词 氨溴索 多巴胺 新生儿 感染性肺炎 疗效评价 ambroxol dopamine neonates infectious pneumonia therapeutic effects evaluation
  • 相关文献

参考文献8

二级参考文献75

  • 1侯文华.盐酸氨溴索治疗新生儿吸入性肺炎的临床疗效[J].中国药物与临床,2013,13(S1):93-94. 被引量:3
  • 2无.儿童社区获得性肺炎管理指南(试行)(下)[J].中华儿科杂志,2007,45(3):223-230. 被引量:207
  • 3Singh R,Bemelman FJ,Hodiamont CJ,et al.The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients:a retrospective before-after study[J].BMC Infect Dis,2016,16(1):90-92.
  • 4Demirdal T,Sari US,Nemli SA,et al.Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii[J].Ann Clin Microbiol Antimicrob,2016,15(1):11-13.
  • 5Webb BJ,Jones B,Dean NC,et al.Empiric antibiotic selection and risk prediction of drug-resistant pathogens in community-onset pneumonia[J].Curr Opin Infect Dis,2016,29(2):167-177.
  • 6Afroze SR,Rahman MR,Barai L,et al.Successful treatment outcome of primary melioidosis pneumonia-a case report from Bangladesh[J].BMC Res Notes,2016,9(1):100-102.
  • 7Falcone M,Tiseo G,Russo A,et al.Hospitalization for Pneumonia is Associated With Decreased 1-Year Survival in Patients With Type 2 Diabetes:Results From a Prospective Cohort Study[J].Medicine(Baltimore),2016,95(5):2531-2533.
  • 8Mulder T,Van Werkhoven CH,Huijts SM,et al.Treatment restrictions and empirical antibiotic treatment of communityacquired pneumonia in elderly patients[J].Neth J Med,2016,74(1):56-58.
  • 9Viasus D,Del Rio-Pertuz G,Simonetti AF,et al.Biomarkers for predicting short-term mortality in community-acquired pneumonia:A systematic review and meta-analysis[J].J Infect,2016,72(3):273-282.
  • 10Duke T.Systemic inflammatory response syndrome and bacteremia in developing countries[J].Pediatr Crit Care Med,2010,11(1):153-154.

共引文献115

同被引文献94

引证文献10

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部